Clinical Feasibility of Disease Managing Mobile App for Hyperthyroidism

Last updated: April 12, 2023
Sponsor: Seoul National University Bundang Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Thyroid Disorders

Female Hormonal Deficiencies/abnormalities

Thyroid Disease

Treatment

N/A

Clinical Study ID

NCT05828732
B-2201-735-304
  • Ages > 18
  • All Genders

Study Summary

This randomized controlled study aims to investigate the effects of using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis. The study intends to evaluate how the use of the app affects disease progression, quality of life, and health-related behaviors associated with the disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects who have been newly diagnosed or are currently undergoing treatment forthyrotoxicosis at Bundang Seoul National University Hospital.
  • Subjects must be able to use the smartphone app required for the use of wearabledevices and their integration.

Exclusion

Exclusion Criteria:

  • Subjects who have constraints on normal activity due to diseases other than thyroiddysfunction.
  • Subjects who are currently taking medication that affects heart rate.
  • Subjects with heart conditions such as arrhythmia that affect heart rate.
  • Subjects who cannot undergo antithyroid drug treatment and require surgery orradioactive iodine therapy.

Study Design

Total Participants: 100
Study Start date:
March 01, 2022
Estimated Completion Date:
December 31, 2023

Connect with a study center

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do 13620
    Korea, Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.